UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007547 |
|---|---|
| Receipt number | R000008900 |
| Scientific Title | Multicenter randomized phase ll study of XELOX plus bevacizumab or XELIRI plusbevacizumab as first-line chemotherapy for metastatic or recurrent colorectal cancer |
| Date of disclosure of the study information | 2012/03/22 |
| Last modified on | 2016/11/16 09:01:49 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/03/21 20:16:48 | ||
| 2 | Update | 2016/06/29 20:23:12 | UMIN ID1 |
|
| 3 | Update | 2016/11/16 08:59:50 | Email Name of person sending information Name of person sending information Name of primary person or sponsor Organization |
|
| 4 | Update | 2016/11/16 09:01:29 | Control Key inclusion criteria |
|
| 5 | Update | 2016/11/16 09:01:49 | Recruitment status |
